A detailed history of Wescap Management Group, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Wescap Management Group, Inc. holds 2,352 shares of CRL stock, worth $430,792. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,352
Previous 2,184 7.69%
Holding current value
$430,792
Previous $451,000 2.66%
% of portfolio
0.12%
Previous 0.13%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$187.96 - $245.29 $31,577 - $41,208
168 Added 7.69%
2,352 $463,000
Q1 2024

May 13, 2024

SELL
$203.52 - $273.43 $3,459 - $4,648
-17 Reduced 0.77%
2,184 $591,000
Q4 2023

Feb 06, 2024

SELL
$164.52 - $238.84 $67,946 - $98,640
-413 Reduced 15.8%
2,201 $520,000
Q3 2023

Nov 13, 2023

SELL
$194.44 - $217.61 $24,305 - $27,201
-125 Reduced 4.56%
2,614 $512,000
Q2 2023

Aug 10, 2023

BUY
$183.71 - $210.25 $28,107 - $32,168
153 Added 5.92%
2,739 $575,000
Q1 2023

May 04, 2023

SELL
$191.89 - $259.92 $36,075 - $48,864
-188 Reduced 6.78%
2,586 $521,000
Q4 2022

Feb 10, 2023

SELL
$197.11 - $250.07 $15,177 - $19,255
-77 Reduced 2.7%
2,774 $604,000
Q3 2022

Nov 02, 2022

SELL
$182.44 - $250.54 $4,743 - $6,514
-26 Reduced 0.9%
2,851 $561,000
Q2 2022

Aug 11, 2022

SELL
$204.13 - $302.4 $11,023 - $16,329
-54 Reduced 1.84%
2,877 $615,000
Q4 2021

Feb 11, 2022

SELL
$351.38 - $448.68 $95,926 - $122,489
-273 Reduced 8.52%
2,931 $1.1 Million
Q3 2021

Nov 12, 2021

SELL
$372.64 - $458.3 $29,065 - $35,747
-78 Reduced 2.38%
3,204 $1.32 Million
Q2 2021

Aug 02, 2021

SELL
$294.17 - $371.65 $77,955 - $98,487
-265 Reduced 7.47%
3,282 $1.21 Million
Q1 2021

May 07, 2021

SELL
$249.67 - $299.48 $23,718 - $28,450
-95 Reduced 2.61%
3,547 $1.03 Million
Q4 2020

Feb 10, 2021

SELL
$222.0 - $252.62 $79,254 - $90,185
-357 Reduced 8.93%
3,642 $909,000
Q3 2020

Nov 12, 2020

SELL
$175.56 - $226.45 $43,363 - $55,933
-247 Reduced 5.82%
3,999 $905,000
Q2 2020

Aug 06, 2020

SELL
$118.84 - $189.72 $32,799 - $52,362
-276 Reduced 6.1%
4,246 $740,000
Q4 2019

Feb 05, 2020

SELL
$126.05 - $152.76 $21,428 - $25,969
-170 Reduced 3.62%
4,522 $690,000
Q3 2019

Nov 13, 2019

SELL
$125.07 - $143.67 $30,266 - $34,768
-242 Reduced 4.9%
4,692 $621,000
Q1 2019

May 06, 2019

SELL
$104.82 - $146.73 $19,391 - $27,145
-185 Reduced 3.61%
4,934 $716,000
Q3 2018

Nov 07, 2018

SELL
$112.11 - $134.54 $180,497 - $216,609
-1,610 Reduced 23.93%
5,119 $688,000
Q2 2018

Aug 07, 2018

SELL
$102.37 - $117.25 $98,275 - $112,560
-960 Reduced 12.49%
6,729 $755,000
Q1 2018

May 03, 2018

SELL
$98.19 - $115.2 $838,542 - $983,808
-8,540 Reduced 52.62%
7,689 $820,000
Q4 2017

Feb 13, 2018

SELL
$100.43 - $118.09 $22,697 - $26,688
-226 Reduced 1.37%
16,229 $1.78 Million
Q3 2017

Nov 08, 2017

BUY
$96.72 - $109.26 $1.59 Million - $1.8 Million
16,455
16,455 $1.78 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.32B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Wescap Management Group, Inc. Portfolio

Follow Wescap Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wescap Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wescap Management Group, Inc. with notifications on news.